Enhanced antitumor activity of a novel, oral, helper epitope-containing WT1 protein vaccine in a model of murine leukemia

por Minagawa, Hikaru, Hashii, Yoshiko, Nakajima, Hiroko, Fujiki, Fumihiro, Morimoto, Soyoko, Nakata, Jun, Shirakawa, Toshiro, Katayama, Takane, Tsuboi, Akihiro, Ozono, Keiichi
Publicado 2023

An oral WT1 protein vaccine composed of WT1-anchored, genetically engineered Bifidobacterium longum allows for intestinal immunity in mice with acute myeloid leukemia

por Nakagawa, Natsuki, Hashii, Yoshiko, Kayama, Hisako, Okumura, Ryu, Nakajima, Hiroko, Minagawa, Hikaru, Morimoto, Soyoko, Fujiki, Fumihiro, Nakata, Jun, Shirakawa, Toshiro, Katayama, Takane, Takeda, Kiyoshi, Tsuboi, Akihiro, Ozono, Keiichi
Publicado 2022

Distinct difference in tumor-infiltrating immune cells between Wilms’ tumor gene 1 peptide vaccine and anti-programmed cell death-1 antibody therapies

por Yokota, Chisato, Nakata, Jun, Takano, Koji, Nakajima, Hiroko, Hayashibara, Hiromu, Minagawa, Hikaru, Chiba, Yasuyoshi, Hirayama, Ryuichi, Kijima, Noriyuki, Kinoshita, Manabu, Hashii, Yoshiko, Tsuboi, Akihiro, Oka, Yoshihiro, Oji, Yusuke, Kumanogoh, Atsushi, Sugiyama, Haruo, Kagawa, Naoki, Kishima, Haruhiko
Publicado 2021